Article info
Original research
Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen
- Correspondence to Dr Bakri Elsheikh; Bakri.elsheikh{at}osumc.edu
Citation
Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen
Publication history
- Received April 22, 2021
- Accepted July 26, 2021
- First published August 12, 2021.
Online issue publication
August 12, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.